AIMC Topic: Product Surveillance, Postmarketing

Clear Filters Showing 11 to 20 of 21 articles

Ontology-based specification and generation of search queries for post-market surveillance.

Journal of biomedical semantics
BACKGROUND: The vigilant observation of medical devices during post-market surveillance (PMS) for identifying safety-relevant incidents is a non-trivial task. A wide range of sources has to be monitored in order to integrate all accessible data about...

Classification-by-Analogy: Using Vector Representations of Implicit Relationships to Identify Plausibly Causal Drug/Side-effect Relationships.

AMIA ... Annual Symposium proceedings. AMIA Symposium
An important aspect of post-marketing drug surveillance involves identifying potential side-effects utilizing adverse drug event (ADE) reporting systems and/or Electronic Health Records. These data are noisy, necessitating identified drug/ADE associa...

First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
The safety and feasibility of robotically-assisted percutaneous coronary intervention (PCI) for simple coronary lesions has been demonstrated. The CorPath robotic system (Corpath 200, Corindus, Waltham, MA) consists of a robotic arm mounted on the ca...

Handling Temporality of Clinical Events for Drug Safety Surveillance.

AMIA ... Annual Symposium proceedings. AMIA Symposium
Using longitudinal data in electronic health records (EHRs) for post-marketing adverse drug event (ADE) detection allows for monitoring patients throughout their medical history. Machine learning methods have been shown to be efficient and effective ...

Leveraging Data Pipeline and LLM to Advance Patient Safety Event Studies.

Studies in health technology and informatics
Research utilizing the open-access MAUDE database frequently reveals unclear methodologies for extracting and processing medical device report (MDR) data, reducing reproducibility and consistency. By harnessing the OpenFDA API and our MAUDE extract-t...

A machine learning framework to adjust for learning effects in medical device safety evaluation.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVES: Traditional methods for medical device post-market surveillance often fail to accurately account for operator learning effects, leading to biased assessments of device safety. These methods struggle with non-linearity, complex learning cu...

Learning to detect and understand drug discontinuation events from clinical narratives.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVE: Identifying drug discontinuation (DDC) events and understanding their reasons are important for medication management and drug safety surveillance. Structured data resources are often incomplete and lack reason information. In this article...

Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVE: The aim of this work is to leverage relational information extracted from biomedical literature using a novel synthesis of unsupervised pretraining, representational composition, and supervised machine learning for drug safety monitoring.